Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids

被引:48
作者
Garevik, Nina [1 ]
Strahm, Emmanuel [1 ]
Garle, Mats [1 ]
Lundmark, Jonas [1 ]
Stahle, Lars [2 ]
Ekstrom, Lena [1 ]
Rane, Anders [1 ]
机构
[1] Karolinska Univ Hosp, Div Clin Pharmacol, Karolinska Inst, SE-14186 Stockholm, Sweden
[2] Astra Zeneca AB, SE-15185 Sodertalje, Sweden
基金
瑞士国家科学基金会;
关键词
Anabolic androgenic steroids; Testosterone; Nandrolone; T/E; BLOOD-PRESSURE; DOPING AGENTS; TESTOSTERONE; SERUM; GLUCURONIDATION; POLYMORPHISM; SOCIETY; LIPIDS; URINE; MEN;
D O I
10.1016/j.jsbmb.2011.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: To study the long-term impact of anabolic androgenic steroid (AAS) abuse on the cholesterol profile, and the potential to suppress endocrine activity in men working out at gym facilities. To study the relation between urinary biomarkers for testosterone and nandrolone abuse and the UGT2B17 genotype and time profile. Experimental design: Subjects (N=56) were recruited through Anti-Doping Hot-Line. Serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), plasma levels of low density lipoprotein (LDL), high density lipoprotein (HDL) and urinary steroid profile were regularly measured for a period of up to one year after cessation of intramuscular AAS abuse. Results and discussion: A sustained suppression of LH, and FSH was observed for several months. The nandrolone urinary biomarker 19-NA was detectable several months after the last nandrolone intake and was correlated to the levels of LH and FSH. Testosterone abuse on the other hand was detectable only for a few weeks, and some of the testosterone abusers did not test positive due to a genetic deletion polymorphism of the UGT2B17. Significantly increased levels of HDL and decreased levels of LDL were observed for 6-months after cessation of AAS abuse. Conclusion: Some individuals had a sustained suppression of LH and FSH for a period of 1 year whereas the cholesterol profile was normalized within 6 month. The long term consequences of these findings remain to be established. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 29 条
[1]   Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm [J].
Achar, Suraj ;
Rostamian, Armand ;
Narayan, Sanjiv M. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06) :893-901
[2]   SERUM-LIPIDS IN POWER ATHLETES SELF-ADMINISTERING TESTOSTERONE AND ANABOLIC-STEROIDS [J].
ALEN, M ;
RAHKILA, P ;
MARNIEMI, J .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1985, 6 (03) :139-144
[3]  
ALEN M, 1985, MED SCI SPORT EXER, V17, P354
[4]   Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: Analysis of serum and urine samples in healthy men [J].
Bagchus, WM ;
Smeets, JMW ;
Verheul, HAM ;
De Jager-Van der Veen, SM ;
Port, A ;
Geurts, TBP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2624-2630
[5]   The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology [J].
Eklöf, AC ;
Thurelius, AM ;
Garle, M ;
Rane, A ;
Sjöqvist, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (8-9) :571-577
[6]   Dual use of anabolic-androgenic steroids and narcotics in Sweden [J].
Garevik, Nina ;
Rane, Anders .
DRUG AND ALCOHOL DEPENDENCE, 2010, 109 (1-3) :144-146
[8]   Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a) [J].
Hartgens, F ;
Rietjens, G ;
Keizer, HA ;
Kuipers, H ;
Wolffenbuttel, BHR .
BRITISH JOURNAL OF SPORTS MEDICINE, 2004, 38 (03) :253-259
[9]   Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism [J].
Jakobsson, J ;
Ekström, L ;
Inotsume, N ;
Garle, M ;
Lorentzon, M ;
Ohlsson, C ;
Roh, HK ;
Carlström, K ;
Rane, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :687-693
[10]   ANABOLIC STEROID-INDUCED HYPOGONADOTROPIC HYPOGONADISM [J].
JAROW, JP ;
LIPSHULTZ, LI .
AMERICAN JOURNAL OF SPORTS MEDICINE, 1990, 18 (04) :429-431